juanhui you are not reading it properly, the prospectus clearly states supply capacity is boosted for fy15 sales. fy14 report is not critical.
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
